IP vs PRAX · P/E 43, $26.62B cap vs rev $8.6M
International Paper (IP) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported PRAX revenue for 2024-12-31 was $8.6M. Net income was -$58.7M. Revenue was up 249.5% from 2023-12-31 to 2024-12-31. PRAX currently screens at market cap $7.38B.
IP currently screens at market cap $26.62B and trailing P/E 43.1. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the IP and PRAX stock pages for the full models.
Not investment advice.